Skip to main content

Table 2 Proportion of HPV genotypes in HPV positive patients

From: Low concordance of oral and genital HPV infection among male patients with sexually transmitted infections in Vietnam

HPV type Genitals, n = 58
(%) [95% CI]
Oral cavity, n = 16
(%) [95% CI]
Overall, n = 69
(%) [95% CI]
High-riska 42 (72.4) [58.9–83.0] 12 (75.0) [47.4–91.7] 50 (72.5) [60.2–82.2]
 16 6 (10.3) [4.3–21.8] 1 (6.3) [0.3–32.3] 7 (10.1) [4.5–20.4]
 18 10 (17.2) [9.0–29.9] 9 (56.3) [30.6–79.3] 19 (27.5) [17.8–39.8]
 31 2 (3.4) [0.6–13.0] 0 2 (2.9) [0.5–11.0]
 33 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 35 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 39 4 (6.9) [2.2–17.6] 1 (6.3) [0.3–32.3] 5 (7.2) [2.7–16.8]
 45 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 51 5 (8.6) [3.2–19.7] 0 5 (7.2) [2.7–16.8]
 52 10 (17.2) [9.0–29.9] 0 10 (14.5) [7.5–25.5]
 56 2 (3.4) [0.6–13.0] 1 (6.3) [0.3–32.3] 3 (4.3) [1.1–13.0]
 58 5 (8.6) [3.2–19.7] 0 5 (7.2) [2.7–16.8]
 59 4 (6.9) [2.2–17.6] 1 (6.3) [0.3–32.3] 5 (7.2) [2.7–16.8]
 68 7 (12.1) [5.4–23.9] 0 7 (10.1) [4.5–20.4]
Low-riska 36 (62.1) [48.4–74.2] 6 (37.5) [16.3–64.1] 41 (59.4) [46.9–70.9]
 30 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 53 3 (5.2) [1.3–15.3] 1 (6.3) [0.3–32.3] 4 (5.8) [1.9–14.9]
 66 1 (1.7) [0.1–10.5] 1 (6.3) [0.3–32.3] 2 (2.9) [0.5–11.0]
 6 7 (12.1) [5.4–23.9] 0 7 (10.1) [4.5–20.4]
 11 7 (12.1) [5.4–23.9] 2 (12.5) [2.2–39.6] 8 (11.6) [5.5–22.1]
 40 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 42 2 (3.4) [0.6–13.0] 1 (6.3) [0.3–32.3] 3 (4.3) [1.1–13.0]
 43 5 (8.6) [3.2–19.7] 0 5 (7.2) [2.7–16.8]
 44 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 74 2 (3.4) [0.6–13.0] 0 2 (2.9) [0.5–11.0]
 76 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
 81 11 (19.0) [10.3–31.8] 1 (6.3) [0.3–32.3] 12 (17.4) [9.7–28.8]
 90 2 (3.4) [0.6–13.0] 0 2 (2.9) [0.5–11.0]
 114 1 (1.7) [0.1–10.5] 0 1 (1.4) [0.1–8.9]
Total strains 103 19 121
  1. CI confidence interval
  2. a“High-risk” and “low-risk” HPV infection were defined as a positive result for at least one of high-risk and low-risk HPV genotypes, respectively